Skip Nav Destination
Treatment of Medication-Related Osteonecrosis of the Jaw Around the Dental Implant With a Once-Weekly Teriparatide: A Case Report and Literature Review
J Oral Implantol (2019) 45 (5): 403–407.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Molecular Targeted Therapy for the Bone Loss Secondary to Pyogenic Spondylodiscitis Using Medications for Osteoporosis: A Literature Review
- Takashi Ohnishi
- Yuki Ogawa
- Kota Suda
- Miki Komatsu
- Satoko Matsumoto Harmon
- Mitsuru Asukai
- Masahiko Takahata
- Norimasa Iwasaki
- Akio Minami
International Journal of Molecular Sciences (2021) 22 (9): 4453.
The role, efficacy and outcome measures for teriparatide use in the management of medication-related osteonecrosis of the jaw
- M. Anabtawi
- H. Tweedale
- H. Mahmood
International Journal of Oral and Maxillofacial Surgery (2021) 50 (4): 501.
Teriparatide Treatment for Medication-Related Osteonecrosis of the Jaw: Is This an Effective Option?
- Yoshinari Myoken
- Yoshinori Fujita
- Shigeaki Toratani
Journal of Clinical Oncology (2021) 39 (2): 172.